Oscar Health, INC Form 4 insider transactions

Vanessa Ames Wittman, a Director of Oscar Health, Inc., sold 25,000 shares of common stock on September 18, 2026 for $32.24 per share.

Joshua Kushner, Co-Founder and Vice Chairman, a Director and 10% owner of Oscar Health, Inc., reported multiple transactions in common stock on September 18, 2026.

Thrive Partners II GP, LLC and 8 others reported changes in beneficial ownership of Oscar Health, Inc. common stock on September 18, 2026.

Janet Liang, President, Oscar Insurance of Oscar Health, Inc., sold 10,360 shares of common stock on September 3, 2026 for $31.45 per share.

Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., sold 958 shares of common stock on September 3, 2026 for $31.45 per share.

Richard Scott Blackley, Chief Financial Officer of Oscar Health, Inc., sold 28,869 shares of common stock on September 3, 2026 for $31.45 per share.

Adam Mcananey, Chief Legal Officer of Oscar Health, Inc., sold 9,092 shares of common stock on September 3, 2026 for $31.45 per share.

Mario Schlosser, a Director of Oscar Health, Inc., sold 31,422 shares of common stock on September 3, 2026 for $31.45 per share.

Mario Schlosser, a Director of Oscar Health, Inc., sold 750,000 shares of common stock on August 27, 2026.

Richard Scott Blackley, Chief Financial Officer of Oscar Health, Inc., sold 18,750 shares of common stock on August 18, 2026 for $31.74 per share.

William Gassen, a Director of Oscar Health, Inc., received 684 shares of common stock on July 9, 2026.

Sid Sankaran, a Director of Oscar Health, Inc., received 858 shares of common stock on July 9, 2026.

David Plouffe, a Director of Oscar Health, Inc., received 681 shares of common stock on July 9, 2026.

Oscar Health Director Mario Schlosser executed a Rule 10b5-1 trading plan, resulting in the sale of a significant number of Class A common stock shares.

Oscar Health CEO Mark Bertolini sold a significant number of Class A common stock shares to cover tax obligations related to vested performance stock units, executing a pre-planned Rule 10b5-1 transaction.

Oscar Health CEO Mark Bertolini sold company stock to cover tax obligations related to vested stock units, executing a pre-planned Rule 10b5-1 trading plan.

Oscar Health Director Mario Schlosser executed a series of transactions involving Class A common stock, including acquisitions and dispositions, on June 23, 2026, under a Rule 10b5-1 trading plan.

Oscar Health, Inc. reports a Form 4 filing detailing a transaction by Director Laura W. Lang, acquiring 8,475 shares of Class A Common Stock.

Oscar Health Director David Plouffe acquired 8,475 shares of Class A Common Stock through restricted stock units.

Oscar Health, Inc. Director Sankaran Sid reported transactions involving Class A Common Stock and Restricted Stock Units.

Oscar Health Director William Gassen acquired 8,475 restricted stock units on June 4, 2026, as detailed in a Form 4 filing.

Oscar Health, Inc. reports that Director Vanessa Ames acquired 8,475 restricted stock units on June 4, 2026.

Oscar Health's Chief Accounting Officer, Victoria Baltrus, sold shares to cover tax obligations from vested equity awards.

Oscar Health Director Mario Schlosser sold 34,120 shares of Class A Common Stock to cover tax obligations from equity award vesting.

Oscar Health's Chief Legal Officer, Adam McAnaney, sold shares of Class A Common Stock to cover tax withholding obligations from vested equity awards.

Oscar Health's President of Oscar Insurance, Janet Liang, has sold a significant number of Class A common stock shares.

Oscar Health's Chief Financial Officer, Richard Scott Blackley, has sold a significant number of Class A Common Stock shares as part of a pre-arranged trading plan.

Oscar Health's Chief Financial Officer, Richard Scott Blackley, has sold a significant number of Class A common stock shares as part of a pre-arranged trading plan.

Oscar Health, Inc. reports that Director Sankaran Sid received 1,203 deferred stock units on April 9, 2026, as part of a compensation plan.

William Gassen, a Director at Oscar Health, Inc., has elected to receive deferred stock units in lieu of cash retainer payments, reflecting a strategic alignment with the company's stock performance.